We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-14.8%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$13.1B
AUM Growth
-$2.86B
Cap. Flow
-$262M
Cap. Flow %
-2%
Top 10 Hldgs %
37.9%
Holding
1,479
New
56
Increased
646
Reduced
399
Closed
58

Sector Composition

Rank Sector Weight
1 Real Estate 60.75%
2 Technology 8.8%
3 Healthcare 4.18%
4 Consumer Discretionary 3.61%
5 Financials 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCM icon
1201
HUTCHMED
HCM
$1.91B
$2K ﹤0.01%
185
IDYA icon
1202
IDEAYA Biosciences
IDYA
$3.49B
$2K ﹤0.01%
132
IGMS
1203
DELISTED
IGM Biosciences
IGMS
$2K ﹤0.01%
88
NBP
1204
NovaBridge Biosciences American Depositary Shares
NBP
$200M
$2K ﹤0.01%
144
IMVT icon
1205
Immunovant
IMVT
$8.09B
$2K ﹤0.01%
394
ITOS
1206
DELISTED
iTeos Therapeutics
ITOS
$2K ﹤0.01%
121
KROS icon
1207
Keros Therapeutics
KROS
$197M
$2K ﹤0.01%
80
MIRM icon
1208
Mirum Pharmaceuticals
MIRM
$6.86B
$2K ﹤0.01%
89
NKTR icon
1209
Nektar Therapeutics
NKTR
$2.36B
$2K ﹤0.01%
36
NKTX icon
1210
Nkarta
NKTX
$157M
$2K ﹤0.01%
180
+67
+59% +$879
NRIX icon
1211
Nurix Therapeutics
NRIX
$2.38B
$2K ﹤0.01%
152
NUVL
1212
DELISTED
Nuvalent
NUVL
$2K ﹤0.01%
125
PMVP icon
1213
PMV Pharmaceuticals
PMVP
$58.7M
$2K ﹤0.01%
132
RAPT
1214
DELISTED
RAPT Therapeutics
RAPT
$2K ﹤0.01%
13
RLMD icon
1215
Relmada Therapeutics
RLMD
$544M
$2K ﹤0.01%
83
RNAM
1216
DELISTED
Avidity Biosciences
RNAM
$2K ﹤0.01%
156
SGMO
1217
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$2K ﹤0.01%
498
STOK icon
1218
Stoke Therapeutics
STOK
$1.81B
$2K ﹤0.01%
126
TBPH icon
1219
Theravance Biopharma
TBPH
$875M
$2K ﹤0.01%
215
TIL icon
1220
Instil Bio
TIL
$48.7M
$2K ﹤0.01%
19
VERV
1221
DELISTED
Verve Therapeutics
VERV
$2K ﹤0.01%
141
VNDA icon
1222
Vanda Pharmaceuticals
VNDA
$308M
$2K ﹤0.01%
191
YMAB
1223
DELISTED
Y-mAbs Therapeutics
YMAB
$2K ﹤0.01%
149
TVRD
1224
Tvardi Therapeutics
TVRD
$23.5M
$2K ﹤0.01%
5
PETQ
1225
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$2K ﹤0.01%
99

Similar funds

Daiwa Securities Group's Q2 2022 Portfolio in Review

As of Q2 2022, Daiwa Securities Group held 1,479 positions worth $13.1B, down 18% from $16B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Daiwa Securities Group's Q2 2022 filing shows 56 new, 646 increased, 399 reduced and 58 closed positions. Its largest new stake was HDFC Bank: 143,030 shares worth $3.93M. The largest sale was American Tower, an estimated $263M.

By sector, the portfolio is most concentrated in Real Estate at 61% of assets, up from 60% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q2 2022 buy was HDFC Bank: 143,030 shares worth $3.93M.
  • Daiwa Securities Group added most to Mid-America Apartment Communities in Q2 2022, an estimated $174M increase.
  • Daiwa Securities Group's biggest Q2 2022 reduction was American Tower, cutting an estimated $263M.
  • Daiwa Securities Group fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $7.68M.
  • Daiwa Securities Group's ten largest holdings make up 38% of its $13.1B portfolio in Q2 2022.
  • Daiwa Securities Group opened 56 new positions and closed 58 in Q2 2022.
  • Daiwa Securities Group's portfolio value fell 18% quarter-over-quarter to $13.1B.

Based on Daiwa Securities Group's 13F filing for Q2 2022, filed 9 Aug 2022.